Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung disease

被引:0
|
作者
Winthrop, Kevin [1 ,2 ]
Waweru, Catherine [3 ]
Hassan, Mariam [3 ]
Burns, Sara [4 ]
Lucci, Matthew [4 ]
Chatterjee, Anjan [3 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Portland State Univ, Sch Publ Hlth, Portland, OR 97207 USA
[3] Insmed Inc, Bridgewater Township, NJ USA
[4] Panalgo, Boston, MA USA
关键词
PULMONARY-DISEASE; AVIUM COMPLEX; DIAGNOSIS; MORTALITY; IMPACT;
D O I
10.1183/23120541.00963-2023
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background While antibiotics are recommended for treatment of nontuberculous mycobacterial lung disease (NTMLD), the impact of early antibiotic initiation on healthcare resource utilisation is unclear. This study compared healthcare resource utilisation with early versus delayed antibiotic initiation in NTMLD. Methods A retrospective, claims database study (Merative MarketScan) of patients diagnosed with NTMLD between 1 July 2015 and 30 June 2019. Patients were divided into early antibiotic initiation, i.e. <= 3 months after the first medical claim for NTMLD (index date), and delayed antibiotic initiation groups. Hospitalisations and outpatient visits during a 2-year post-index period were compared to baseline per treatment group; a difference-in-difference analysis compared early and delayed antibiotic initiation groups adjusting for confounding. Results Out of 481 NTMLD treated patients, 364 (76%) and 117 (24%) comprised the early and delayed antibiotic initiation groups, respectively. The early antibiotic initiation group showed significant reductions from baseline in hospitalisations (all-cause, respiratory) and emergency department (ED) visits at follow-up. A significant increase from baseline in mean number of hospitalisations per patient was observed in the delayed antibiotic initiation group in year 1 post-index. Compared to delayed antibiotic initiation, the early antibiotic initiation group showed significantly greater reductions in all-cause hospitalisations in years 1 and 2 post-index (relative risk 0.62 (95% CI 0.41-0.95) and 0.62 (95% CI 0.39-0.98), respectively), and in respiratory-related hospitalisations. Conclusions The early antibiotic initiation group showed significant reductions from baseline in hospitalisations and ED visits over time. Compared to delayed antibiotic initiation, early antibiotic initiation was associated with significantly greater reductions in hospitalisations.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The association between body shape and nontuberculous mycobacterial lung disease
    Talbert, Janet
    Chan, Edward D.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (03) : 201 - 204
  • [32] Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Seitz, Amy E.
    Holland, Steven M.
    Prevots, D. Rebecca
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (08) : 881 - 886
  • [33] Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
    Aksamit, Timothy R.
    Philley, Julie V.
    Griffith, David E.
    RESPIRATORY MEDICINE, 2014, 108 (03) : 417 - 425
  • [34] Recent advances and controversies in surgical intervention of nontuberculous mycobacterial lung disease: A literature review
    Tseng, Yu-Ting
    Pan, Chien-Te
    Yang, Shun-Mao
    Yu, Sheng-Pin
    Huang, Pei-Ming
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : 576 - 583
  • [35] Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches
    Kwon, Yong-Soo
    Daley, Charles L.
    Koh, Won-Jung
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (09) : 851 - 861
  • [36] Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease
    Parikh, Aashka
    Vinnard, Christopher
    Fahrenfeld, Nicole
    Davidow, Amy L.
    Patrawalla, Amee
    Lardizabal, Alfred
    Gow, Andrew
    Panettieri, Reynold
    Gennaro, Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (21)
  • [37] The Impact of Low Subcutaneous Fat in Patients with Nontuberculous Mycobacterial Lung Disease
    Lee, Seok Jeong
    Ryu, Yon Ju
    Lee, Jin Hwa
    Chang, Jung Hyun
    Shim, Sung Shine
    LUNG, 2014, 192 (03) : 395 - 401
  • [38] Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease
    Kang, Hyung Koo
    Park, Hye Yun
    Kim, Dohun
    Jeong, Byeong-Ho
    Jeon, Kyeongman
    Cho, Jong Ho
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Koh, Won-Jung
    BMC INFECTIOUS DISEASES, 2015, 15
  • [39] Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient
    Park, Jae Seok
    Lee, Wonmok
    Jeon, Young June
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [40] Randomized Trial of Liposomal Amikacin for Inhlation in Nontuberculous Mycobacterial Lung Disease
    Olivier, Kenneth N.
    Griffith, David E.
    Eagle, Gina
    McGinnis, John P., II
    Micioni, Liza
    Liu, Keith
    Daley, Charles L.
    Winthrop, Kevin L.
    Ruoss, Stephen
    Addrizzo-Harris, Doreen J.
    Flume, Patrick A.
    Dorgan, Daniel
    Salathe, Matthias
    Brown-Elliott, Barbara A.
    Gupta, Renu
    Wallace, Richard J., Jr.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (06) : 814 - 823